According to Obesity Canada guidance: Adults (18+) are eligible for all GLP-1-based weight-loss medications Adolescents (12 years old) may be eligible for certain agents (e.g., liraglutide and semaglutide) depending on clinical context and approval status use in younger populations requires specialist involvement
What FDA-approved treatments or non-drug options are available, and why might they be preferred
Book Your Medical Evaluation Difficulty losing weight despite repeated efforts Constant hunger, cravings, or trouble with portion control Weight regain after past diets or short-term programs Interest in GLP-1 treatment with real medical oversight A need for accountability, follow-up, and a plan that can be adjusted A desire to build toward long-term maintenance, not just temporary loss How the Program Works Every plan starts with a real evaluation and continues with support, adjustment, and follow-up as your needs evolve
A preservative can limit some bacterial growth, but it does not replace aseptic technique or make a contaminated vial safe. Why are peptide vials allowed to warm before reconstitution
9 Multiple GGT isoforms are expressed in cancer cell lines, but none score as essential in genome-wide genetic screens
